JUN 19, 2018 06:07 AM PDT

Three-Dimensional Diagnosis of Osteoarthritis

WRITTEN BY: Kara Marker

There is a new way to diagnose arthritis and watch its progression slowly over time to determine the best route of treatment. From the University of Cambridge, scientists introduce an algorithm based on three-dimensional imaging scans to monitor arthritis.

Micrograph showing degenerative joint disease compatible with osteoarthritis. Credit: Nephron

Unlike existing methods, the new approach can detect the smallest changes in arthritic joints. This way, scientists and physicians could test new treatments and understand more about how the disease develops. Learning more about arthritis could help experts better define the differences between severe cases and minor cases of arthritis.

Osteoarthritis is a degenerative joint disease, the most common chronic condition of the joints. It develops when the cartilage that cushions joint movement deteriorates, causing stiffness, swelling, and pain. Excess weight, injury, and overuse can increase the risk of osteoarthritis, and it can only be treated with surgery to replace joints with an artificial alternative.

Current diagnostic methods for osteoarthritis include x-ray imaging, scans of which would show a loss of joint cartilage in joints between bones. However, this method requires human interpretation, which can vary, and it can’t effectively keep track of small changes in joint deterioration over time.

"Our ability to detect structural changes to identify disease early, monitor progression and predict treatment response is frustratingly limited by this,” said lead author Dr. Tom Turmezei.

The new technique is called joint space mapping (JSM), and it uses three-dimensional images from a standard computerized tomography (CT) scan. A CT scan produces cross-sectional images of anatomy, uses only low doses of radiation, and can be used by clinicians to diagnose and monitor various health conditions.

CT scan-directed JSM can successfully identify even the smallest changes in the space between the bones of an arthritic joint. Researchers conducted tests on human hip joints to develop an algorithm for diagnosing osteoarthritis with JSM, and they found that the new test is twice as sensitive – possibly more – as x-rays at detecting small structural changes in the joint

"Using this technique, we'll hopefully be able to identify osteoarthritis earlier, and look at potential treatments before it becomes debilitating," Turmezei explained. "It could be used to screen at-risk populations, such as those with known arthritis, previous joint injury, or elite athletes who are at risk of developing arthritis due to the continued strain placed on their joints."

The present study was published in the journal Scientific Reports.

Source: Arthritis Foundation, U.S. Food and Drug Administration, University of Cambridge

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
APR 24, 2018
Clinical & Molecular DX
APR 24, 2018
An Atlas of the Human Genome
Scientists from the Hebrew University of Jerusalem want to identify individual genes responsible for specific diseases. This goal inspired their new Nature...
APR 25, 2018
Clinical & Molecular DX
APR 25, 2018
Why is dementia going unnoticed in hospitals?
A study in the UK showed that while the rate of diagnosis for dementia is improving, more than a third of all dementia patients still go undiagnosed. The n...
MAY 28, 2018
Clinical & Molecular DX
MAY 28, 2018
Bacterial Toxin Linked to Inflammatory Bowel Disease
Scientists have found evidence that it's not a bacterium, but one of its toxins, that is connected to, and possibly causing intestinal dysfunction....
AUG 22, 2018
Clinical & Molecular DX
AUG 22, 2018
New Clinical Assay Useful For Urothelial Cancer
U.S. Food and Drug Administration (FDA) has now approved a pharmDx assay called ‘Dako PD-L1 IHC 22C3’ by Agilent Technologies Inc. for use in u...
SEP 01, 2018
Clinical & Molecular DX
SEP 01, 2018
Spit Test for Zika Evolves From HIV Detection
Researchers are developing a test for Zika that uses saliva to identify diagnostic markers of the virus much more quickly than current commercial tests can...
OCT 16, 2018
Microbiology
OCT 16, 2018
Simple Test Rapidly Diagnoses Antibiotic-resistant Infections
If we get a bacterial infection, doctors use antibiotics to treat it. But sometimes people are infected by pathogens that are resistant to drugs....
Loading Comments...